Insights from 2024 EHA Annual Meeting

 

Insights from 2024 EHA Annual Meeting
J

Responder Analysis From the PhALLCON Trial: Ponatinib vs. Imatinib in Newly Diagnosed Ph+ ALL

By Insights from 2024 EHA Annual Meeting FEATURING Jose-Maria Ribera
By Insights from 2024 EHA Annual Meeting FEATURING Jose-Maria Ribera
107 views
June 24, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

15:43
Incyte

Importance of Early Management of Patients with Myelofibrosis (MF)

Feat. P. Bose, R. Rampal

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison
Videos
15:07

Highlights of Recent Updates in CML: Impact on Practice

2024 ASCO® Annual Meeting Insights Hub

E. Atallah

54 views
10:39

EHA 2024 Insights: OMS906, a Novel MASP-3 Inhibitor, in PNH Patients…

Insights from 2024 EHA Annual Meeting

M. Griffin

35 views
19:09

Biological Highlights in CML From EHA

International CML Foundation

N. Cross

50 views
16:02

Clinical Highlights in CML From EHA

International CML Foundation

A. Hochhaus

47 views
13:38

Top 5 Impactful MPN Abstracts From Summer Conferences

Insights from 2024 EHA Annual Meeting

P. Bose

159 views
06:45

EHA 2024 Insights: Relationship Between Hemoglobin and QoL in Transf…

Insights from 2024 EHA Annual Meeting

E. Oliva

31 views
02:01

EHA 2024 Insights: Real-World Data From R/R BPDCN Treated With Tagra…

Insights from 2024 EHA Annual Meeting

E. Angelucci

228 views
14:27

EHA 2024 Insights: Limited Stage HL - Current SOC, Future Directions…

Insights from 2024 EHA Annual Meeting

S. Park

60 views
07:33

EHA 2024 Insights: Sonrotoclax and Zanubrutinib Combination Therapy …

Insights from 2024 EHA Annual Meeting

C. Tam

26 views
13:17

EHA 2024 Insights: Golcadomide, an Oral CELMoD, + R-CHOP in Patients…

Insights from 2024 EHA Annual Meeting

M. Hoffmann

35 views
27:49

AML, MDS, and CML Highlights & Key Takeaways From ASCO®/EHA 2024

Insights from 2024 EHA Annual Meeting

T. Badar

801 views
14:47

EHA 2024 Insights: Treatment of Advanced Stage, High-Risk Hodgkin's …

Insights from 2024 EHA Annual Meeting

M. Salamoon

168 views
13:58

EHA 2024 Insights: Intrathecal Rituximab + Dex for Refractory Sanctu…

Insights from 2024 EHA Annual Meeting

M. Salamoon

129 views
06:03

EHA 2024 Insights: Zanubrutinib vs. Acalabrutinib in B-cell Malignan…

Insights from 2024 EHA Annual Meeting

T. Munir

81 views
09:15

EHA 2024 Insights: Low-Molecular-Weight Heparin and VTE in Newly Dia…

Insights from 2024 EHA Annual Meeting

M. Lauw

86 views
06:55

EHA 2024 Insights: Results by Cytogenetic Risk From PERSEUS - Dara-V…

Insights from 2024 EHA Annual Meeting

M. Dimopoulos

71 views
06:31

EHA 2024 Insights: Impact of Anemia on Clinical Outcomes in MF Patie…

Insights from 2024 EHA Annual Meeting

H. Kathrin Al-Ali

111 views
08:01

EHA 2024 Insights: Sonrotoclax + Zanubrutinib in R/R CLL/SLL

Insights from 2024 EHA Annual Meeting

S. Opat

55 views
14:32

EHA 2024 Insights: Infectious Complications in BCMA- and GPRC5D-Targ…

Insights from 2024 EHA Annual Meeting

J. Mersi

30 views
03:52

EHA 2024 Insights: FLAG-GO vs. FLAG-IDA in Untreated Core Binding Fa…

Insights from 2024 EHA Annual Meeting

G. Borthakur

150 views
04:03

EHA 2024 Insights: PROs After Epcoritamab in R/R Follicular Lymphoma

Insights from 2024 EHA Annual Meeting

W. Jurczak

34 views
05:27

EHA 2024 Insights: Updated Trends in Real-World Outpatient Administr…

Insights from 2024 EHA Annual Meeting

R. Bansal

36 views
06:39

EHA 2024 Insights: Axicabtagene Ciloleucel in R/R Primary Mediastina…

Insights from 2024 EHA Annual Meeting

J. Galtier

22 views
12:32

EHA 2024 Insights: Sequential Administration of Bispecific Antibodie…

Insights from 2024 EHA Annual Meeting

D. Fandrei

123 views
06:51

EHA 2024 Insights: SYMPATICO Study - Ibrutinib + Venetoclax in MCL W…

Insights from 2024 EHA Annual Meeting

W. Jurczak

43 views
10:03

EHA 2024 Insights: SEQUOIA Trial Arm D - Zanubrutinib + Venetoclax f…

Insights from 2024 EHA Annual Meeting

P. Ghia

163 views
12:04

EHA 2024 Insights: The Impact of TP53 Mutation Burden on Risk & Trea…

Insights from 2024 EHA Annual Meeting

M. Salamoon

200 views
06:54

EHA 2024 Insights: CD20-Targeted CAR-T Therapy for BTKi-Refractory W…

Insights from 2024 EHA Annual Meeting

M. Shadman

66 views
05:41

EHA 2024 Insights: Advantages of Using Venetoclax-Based Therapy in H…

Insights from 2024 EHA Annual Meeting

C. Coombs

89 views
06:30

EHA 2024 Insights: QuANTUM-First Trial - Newly Diagnosed FLT3-ITD+ A…

Insights from 2024 EHA Annual Meeting

E. Oliva

134 views
11:23

EHA 2024 Insights: Final 5-Year Results of Olutasidenib for Mutated …

Insights from 2024 EHA Annual Meeting

J. Cortés

27 views
14:39

EHA 2024 Insights: REVIVE Study - Updated Long-Term Results of Hepci…

Insights from 2024 EHA Annual Meeting

K. Pettit

24 views
04:33

EHA 2024 Insights: Daratumumab for iTTP

Insights from 2024 EHA Annual Meeting

J. Weisinger

138 views
36:10

Highlights in Plasma Cell Disorders From ASCO® and EHA

Insights from 2024 EHA Annual Meeting

S. Al Hadidi

483 views
09:52

EHA 2024 Insights: AML Highlights - Focus on Menin Inhibitors

Insights from 2024 EHA Annual Meeting

J. Zeidner

69 views
11:40

EHA 2024 Insights: FLAG-IDA + Venetoclax in Newly Diagnosed or R/R A…

Insights from 2024 EHA Annual Meeting

W. Jen

253 views
10:27

Responder Analysis From the PhALLCON Trial: Ponatinib vs. Imatinib i…

Insights from 2024 EHA Annual Meeting

J. Ribera

107 views
19:14

Experts Discuss Highlights and Key Takeaways in CLL From ASCO® and E…

2024 ASCO® Annual Meeting Insights Hub

K. Rogers, J. Woyach

325 views
07:38

EHA 2024 Insights: TRANSCEND NHL 001 Study - Liso-Cel in R/R MCL - A…

Insights from 2024 EHA Annual Meeting

M. Kamdar

58 views
12:24

EHA 2024 Insights: PERSEUS Trial MRD Analysis: Dara + VRd in Transpl…

Insights from 2024 EHA Annual Meeting

P. Sonneveld

98 views
12:00

EHA 2024 Insights: QUAZAR AML-001 - Oral Azacitidine Maintenance in …

Insights from 2024 EHA Annual Meeting

M. Teresa Voso

93 views